Partnership Opportunities

Strengthen Past Partnerships & Forge New Ones at the 6th Annual Allogeneic Cell Therapies Summit

Following recent strategic partnerships and with investors eagerly awaiting incoming clinical data, momentum is building for allogeneic cell therapies.

Our expert speakers and attendees are looking to get ahead of this wave of investment by progressing their clinical pipelines and upgrading their manufacturing capabilities. However, they still need help overcoming key bottlenecks so they can capitalize on this growing excitement.

Make the most of partnership opportunities at this meeting to showcase your trusted expertise. Be a catalyst for growth in this exciting area and position yourself ahead of the trend, as more players in biopharma turn towards the vast opportunities presented by allogeneic cell therapies.

Schedule a call today to explore opportunities.

“This was an excellent conference for connecting with colleagues involved in the field of allogeneic cell therapies -
agenda was well-thought out and structured to support attendees in participating in those sessions that were of highest relevance”

American Red Cross

Our 2024 Partners:

Program Partner Banner
Allo 2024 Partner banner

“Excellent meeting with high quality lead potential”

Axion Biosystems

Why Partner?

Allo Stickers - Icons 1

Brand Exposure

Position your brand prominently and showcase cutting-edge solutions to an exclusive audience actively seeking services for their allogeneic products

Allo Stickers - Icons 3

Thought Leadership

Spotlight your contributions across the allogeneic field from donor sourcing to cell banking and cryopreservation among leading experts in the biopharma industry

Allo Stickers - Icons 4

Networking Opportunities

Forge invaluable connections with decision-makers and key opinion leaders, unlocking doors to collaborative partnerships and business opportunities

Allo Stickers - Icons 6

Harness Market Intelligence

Gain invaluable insights into the solutions and services that biopharma companies will be investing in to facilitate the large-scale production of allogeneic cell therapeutics in 2024 and beyond!

“The summit was professionally run, well attended by industry leaders and provided strong content”


Become a Partner